Access the 2023 Avalere Healthcare Industry Outlook

First Name*

Last Name*

Email*

Company*

Title*

Industry*

-- Please Select --Angel InvestorAssociation - Health PlansAssociation - Life SciencesAssociation - OtherAssociation - Post Acute/Long Term CareAssociation - ProvidersConsultantDisease Management CompanyDistributorsEmployerFinancial LenderFinancial ServicesFoundationGovernmentHealth Insurers & Health PlansHealth IT CompanyHedge FundHospital SystemsInvestment BankMedical Device ManufacturersMutual Fund / Money ManagerOtherOther - InvestorOther - Life SciencesOther - ProviderPartnershipsPatient/Disease GroupPharmacyPharmacy Benefit ManagerPharmaceutical & Biotech ManufacturersPost Acute Care/Long Term CarePressPrivate EquitySpecialty PharmacyUniversityVenture Capital

Business Unit*

Brand Team/New Products

Business Development

Communications

Corporate

C-Suite & Senior Leadership

Diagnostics

Finance

GA/Public Policy

HEOR

Managed Markets

Marketing/Sales

Market Research

Medical Affairs

R&D

Regulatory

Specialty

Strategy

Which of these methods do you prefer for consuming Avalere’s thought leadership?*

Live webinars

Recorded videos on-demand

Podcasts

Written materials on website

Written materials sent by email

Infographics

Social media posts

None of the above

Select all of the topics in the categories below you would like Avalere’s subject matter experts to address in 2023 webinars or other published content.*

IRA Implementation:*

Interaction among new pricing policies in the IRA

The impact of Part D redesign and negotiation on formulary management / utilization / net price

Preparations plans and manufacturers can make for Medicare risk adjustment changes

Impact of IRA on healthcare investment

None of the above

Quality and Value:*

New approaches to evidence generation and communicating product value

Incorporating patient centric value frameworks into care planning

How global value and evidence standards may influence the US health industry

Redefining quality for health plans

Impact of the Enhancing Oncology Model on treatment selection and care delivery

None of the above

Health in the Community:*

Data-driven strategies to improve health equity

Evolution of the 340B Program

Changes in vaccine coverage requirements / preventive care / reproductive health

The end of the Public Health Emergency and Medicaid maintenance of effort requirement

None of the above

Are you in the European Union or Switzerland?*

-- Please Select --NoYes

The information you provide will be used in accordance with the terms of our privacy policy.

I accept the privacy policy. *

To view our Privacy Policy, see the link in the footer of the page.